SINGH RAJINDER 4
4 · ChemoCentryx, Inc. · Filed Jan 3, 2019
Insider Transaction Report
Form 4
SINGH RAJINDER
SVP, Research
Transactions
- Exercise/Conversion
Common Stock
2019-01-01+5,000→ 19,330 total - Tax Payment
Common Stock
2019-01-01$10.91/sh−8,716$95,092→ 10,614 total - Exercise/Conversion
Restricted Stock Units
2019-01-01−5,000→ 10,000 total→ Common Stock (5,000 underlying) - Exercise/Conversion
Common Stock
2019-01-01+10,000→ 14,330 total - Exercise/Conversion
Restricted Stock Units
2019-01-01−10,000→ 10,000 total→ Common Stock (10,000 underlying)
Footnotes (6)
- [F1]Shares were acquired upon vesting of restricted stock units awarded on February 28, 2017.
- [F2]Shares were acquired upon vesting of restricted stock units awarded on March 5, 2018.
- [F3]Represents shares withheld upon vesting of restricted stock units to satisfy tax withholding obligation.
- [F4]Each restricted stock unit represents a contingent right to receive one share of CCXI common stock.
- [F5]The restricted stock units awarded on February 28, 2017, vest in three equal installments on January 1, 2018, January 1, 2019, and January 1, 2020, subject to the Reporting Person's continued service to the Company on such date. Shares will be delivered to the Reporting Person within thirty (30) days following the vesting date.
- [F6]The restricted stock units awarded on March 5, 2018, vest in three equal installments on January 1, 2019, January 1, 2020, and January 1, 2021, subject to the Reporting Person's continued service to the Company on such date. Shares will be delivered to the Reporting Person within thirty (30) days following the vesting date.